ArticleFrontiers in public health2025
Outcomes of a tribal community program on hepatitis C, HIV, and syphilis screening, confirmation testing, and treatment initiation for an underserved population.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Point-of-Care Hepatitis C Testing in a Tribal Setting.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: American Indian and Alaska Native people are disproportionately impacted by hepatitis C, HIV, and syphilis, with rates 2.3, 1.9, and 6.4 times that of non-Hispanic White people, respectively. The objective was to describe the first 9 months implementing a community-based tribal program to screen and link underserved people to hepatitis C, HIV, and syphilis care and treatment. An additional objective was to identify patient characteristics associated with completing confirmation testing when indicated. Methods: This study occurred from January through September 2024 on the Cherokee Nation reservation in Oklahoma. Survey and medical record data from Cherokee Nation's Hepatitis C Engagement and Linkage Program, a collaboration between the Cherokee Nation Health Services and community programs servicing people with substance use disorders and/or reduced healthcare access. People 18 years and older who visited the organizations during the project period and provided consent were eligible. Project outcomes, including point of care screening results, receipt of confirmation testing, test results, and treatment initiation, were assessed using counts and proportions. Associations between patient characteristics and completion of confirmation testing were assessed using Chi-square or Fisher's exact tests. Results: The program screened 503 people, including 365 American Indian and Alaska Native people, for hepatitis C, HIV, and syphilis. Forty-five percent of participants reported lifetime injection drug use. Overall, 102 (20%) participants had a reactive hepatitis C antibody test, 36 (35%) of whom received confirmatory hepatitis C RNA testing. Sixteen people were diagnosed with hepatitis C infection, 12 (75%) of whom initiated treatment. Sixty participants (12%) had a reactive Conclusion: Cherokee Nation successfully screened underserved individuals for hepatitis C, HIV, and syphilis with moderate success in further evaluation and treatment. Future interventions should include onsite treatment options to prevent barriers to accessing healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.